cancer-related fatigue
Conditions
Interventions
Experimental group:ADQ807 combined with chemotherapy
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meets Western medical criteria for breast cancer diagnosis, with a definitive diagnosis confirmed by pathological examination. (2) Meets the diagnostic criteria for cancer-related fatigue. (3) Women aged =18 and =75 years old. (4) Meets the diagnostic criteria for deficiency syndrome in traditional Chinese medicine. (5) Breast cancer patients undergoing chemotherapy with a 21-day cycle. (6) ECOG score 0-2 points. (7) Voluntarily participate in this clinical study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Pregnant or breastfeeding women. (2) Unable to cooperate in completing data collection or incomplete data. (3) Patients with severe cardiovascular disease, liver and kidney disease, and blood disorders. (4) For those who are allergic to certain drugs in ADQ807. (5) Patients with a history of mental illness. (6) Researchers determined that patients with other life-threatening diseases were not eligible for enrollment. (7) Those participating in other drug trials. (8) During the period of taking this medicine, those who take other Chinese herbal medicines orally.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The revised Piper Fatigue Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional Assessment of Cancer Therapy-Breast;TCM Syndrome Score Scale;Plasma Metabolomics;Plasma genomics;Plasma cytokine chip;Urine metabolomics testing;Fecal intestinal flora testing; | — |
Countries
China
Contacts
Public ContactZhiyu Wang
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed